GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (NAS:CDMO) » Definitions » Cyclically Adjusted PS Ratio

Avid Bioservices (Avid Bioservices) Cyclically Adjusted PS Ratio : 4.65 (As of Jun. 08, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Avid Bioservices Cyclically Adjusted PS Ratio?

As of today (2024-06-08), Avid Bioservices's current share price is $7.96. Avid Bioservices's Cyclically Adjusted Revenue per Share for the quarter that ended in Jan. 2024 was $1.71. Avid Bioservices's Cyclically Adjusted PS Ratio for today is 4.65.

The historical rank and industry rank for Avid Bioservices's Cyclically Adjusted PS Ratio or its related term are showing as below:

CDMO' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.11   Med: 5.08   Max: 24.59
Current: 4.66

During the past years, Avid Bioservices's highest Cyclically Adjusted PS Ratio was 24.59. The lowest was 1.11. And the median was 5.08.

CDMO's Cyclically Adjusted PS Ratio is ranked better than
54.17% of 504 companies
in the Biotechnology industry
Industry Median: 5.47 vs CDMO: 4.66

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Avid Bioservices's adjusted revenue per share data for the three months ended in Jan. 2024 was $0.534. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $1.71 for the trailing ten years ended in Jan. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Avid Bioservices Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Avid Bioservices's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices Cyclically Adjusted PS Ratio Chart

Avid Bioservices Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.82 4.57 15.71 9.08 11.13

Avid Bioservices Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.11 11.13 7.60 3.68 3.96

Competitive Comparison of Avid Bioservices's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Avid Bioservices's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avid Bioservices's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avid Bioservices's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Avid Bioservices's Cyclically Adjusted PS Ratio falls into.



Avid Bioservices Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Avid Bioservices's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=7.96/1.71
=4.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avid Bioservices's Cyclically Adjusted Revenue per Share for the quarter that ended in Jan. 2024 is calculated as:

For example, Avid Bioservices's adjusted Revenue per Share data for the three months ended in Jan. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=0.534/130.1244*130.1244
=0.534

Current CPI (Jan. 2024) = 130.1244.

Avid Bioservices Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201404 0.256 100.023 0.333
201407 0.215 100.520 0.278
201410 0.245 100.176 0.318
201501 0.218 98.604 0.288
201504 0.346 99.824 0.451
201507 0.343 100.691 0.443
201510 0.327 100.346 0.424
201601 0.207 99.957 0.269
201604 0.546 100.947 0.704
201607 0.164 101.524 0.210
201610 0.668 101.988 0.852
201701 0.288 102.456 0.366
201704 0.407 103.167 0.513
201707 0.603 103.278 0.760
201710 0.283 104.070 0.354
201801 0.151 104.578 0.188
201804 0.131 105.708 0.161
201807 0.226 106.324 0.277
201810 0.182 106.695 0.222
201901 0.246 106.200 0.301
201904 0.304 107.818 0.367
201907 0.272 108.250 0.327
201910 0.326 108.577 0.391
202001 0.241 108.841 0.288
202004 0.222 108.173 0.267
202007 0.446 109.318 0.531
202010 0.368 109.861 0.436
202101 0.363 110.364 0.428
202104 0.435 112.673 0.502
202107 0.484 115.183 0.547
202110 0.411 116.696 0.458
202201 0.493 118.619 0.541
202204 0.344 121.978 0.367
202207 0.579 125.002 0.603
202210 0.559 125.734 0.579
202301 0.550 126.223 0.567
202304 0.620 127.992 0.630
202307 0.600 128.974 0.605
202310 0.402 129.810 0.403
202401 0.534 130.124 0.534

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Avid Bioservices  (NAS:CDMO) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Avid Bioservices Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Avid Bioservices (Avid Bioservices) Business Description

Traded in Other Exchanges
Address
14191 Myford Road, Tustin, CA, USA, 92780
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.
Executives
Matthew R. Kwietniak officer: Chief Commercial Officer 14191 MYFORD ROAD, TUSTIN CA 92780
Richard A. Richieri officer: Chief Operations Officer 14191 MYFORD ROAD, TUSTIN CA 92780
Daniel Ryan Hart officer: Chief Financial Officer 2642 MICHELLE DR., SUITE 200, TUSTIN CA 62780
Mark R Ziebell officer: V.P., General Counsel 14282 FRANKLIN AVENUE, TUSTIN CA 92780
Richard B Hancock director 14282 FRANKLIN AVE., TUSTIN CA 92780
Joseph Carleone director 3883 HOWARD HUGHES PKWY, SUITE 700, LAS VEGAS NV 89169
Nicholas Stewart Green director, officer: President & CEO 2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780
Gregory Sargen director
Esther M. Alegria director 2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780
Mark R Bamforth director 500 KENDALL ST., CAMBRIDGE MA 02142
Jeanne Thoma director C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE MN 56623
Patrick D Walsh director 14282 FRANKLIN AVE., TUSTIN CA 92780
Catherine J Mackey director 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121
Joel Mccomb director 9885 TOWNE CENTRE DRIVE, SAN DIEGO CA 92121
Stephen Michael Hedberg officer: Principal Fin. & Acct. Officer 2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780

Avid Bioservices (Avid Bioservices) Headlines

From GuruFocus